These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 32394478)

  • 1. Pain reduction realized with extracorporeal shock wave therapy for the treatment of symptoms associated with interstitial cystitis/bladder pain syndrome-A prospective, multicenter, randomized, double-blind, placebo-controlled study.
    Chuang YC; Meng E; Chancellor M; Kuo HC
    Neurourol Urodyn; 2020 Jun; 39(5):1505-1514. PubMed ID: 32394478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improves symptoms and urinary biomarkers in refractory interstitial cystitis/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo.
    Shen YC; Tyagi P; Lee WC; Chancellor M; Chuang YC
    Sci Rep; 2021 Apr; 11(1):7558. PubMed ID: 33824389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective, Randomized, Double-blind, Placebo-controlled, Pilot Study of Extracorporeal Shock Wave Therapy for Detrusor Underactivity/Underactive Bladder.
    Shen YC; Chen CH; Chancellor MB; Chuang YC
    Eur Urol Focus; 2023 May; 9(3):524-530. PubMed ID: 36437222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Bosch PC
    Eur Urol; 2018 Nov; 74(5):623-630. PubMed ID: 30072210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Kuo HC; Jiang YH; Tsai YC; Kuo YC
    Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
    J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intravesical instillation of KRP-116D (50% dimethyl sulfoxide solution) for interstitial cystitis/bladder pain syndrome in Japanese patients: A multicenter, randomized, double-blind, placebo-controlled, clinical study.
    Yoshimura N; Homma Y; Tomoe H; Otsuka A; Kitta T; Masumori N; Akiyama Y; Niimi A; Mitsui T; Nanri M; Namima T; Takei M; Yamaguchi A; Sekiguchi Y; Kajiwara M; Kobayashi S; Ameda K; Ohashi Y; Sakamoto S; Muraki O; Shishido T; Kageyama S; Kokura K; Okazoe H; Yamanishi T; Watanabe T; Uno T; Ohinata A; Ueda T
    Int J Urol; 2021 May; 28(5):545-553. PubMed ID: 33580603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
    Bosch PC
    J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal shock wave therapy for treatment of vulvodynia: a prospective, randomized, double-blind, placebo-controlled study.
    Hurt K; Zahalka F; Halaska M; Rakovicova I; Krajcova A
    Eur J Phys Rehabil Med; 2020 Apr; 56(2):169-174. PubMed ID: 31939265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of low-intensity extracorporeal shock wave therapy in the management of interstitial cystitis/bladder pain syndrome patients: A thirty case study in a tertiary medical center.
    Jhang LS; Hsieh WC; Huang TX; Chou YC; Lo TS; Liang CC; Lin YH
    Neurourol Urodyn; 2023 Jan; 42(1):65-72. PubMed ID: 36177673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the SHIP1 Pathway Fails to Show Treatment Benefit in Interstitial Cystitis/Bladder Pain Syndrome: Lessons Learned from Evaluating Potentially Effective Therapies in This Enigmatic Syndrome.
    Nickel JC; Moldwin R; Hanno P; Dmochowski R; Peters KM; Payne C; Wein A
    J Urol; 2019 Aug; 202(2):301-308. PubMed ID: 31090511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome.
    Yu WR; Peng TC; Yeh HL; Kuo HC
    Neurourol Urodyn; 2019 Aug; 38(6):1602-1610. PubMed ID: 31059599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete response to acupuncture therapy in female patients with refractory interstitial cystitis/bladder pain syndrome.
    Sönmez MG; Kozanhan B
    Ginekol Pol; 2017; 88(2):61-67. PubMed ID: 28326514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Hanno P; Kumar K; Thomas H
    Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-standing nonulcerative bladder pain syndrome: Impact of Thiele massage on bladder and sexual domains.
    El-Hefnawy AS; Soliman HMM; Abd-Elbary SOM; Shereif WI
    Low Urin Tract Symptoms; 2020 May; 12(2):123-127. PubMed ID: 31647172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of electroacupuncture on refractory interstitial cystitis/bladder pain syndrome: A one-year follow-up case report.
    Gao N; Zeng X; Wu L; Lin Z; Wang X; Wang W
    Explore (NY); 2024; 20(4):602-605. PubMed ID: 38072764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Percutaneous Tibial Nerve Stimulation for Treatment of Refractory Painful Bladder Syndrome.
    Ragab MM; Tawfik AM; Abo El-enen M; Elnady M; El-Gamal OM; El-Kordy M; Gameel T; Rasheed M
    Urology; 2015 Oct; 86(4):707-11. PubMed ID: 26188120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic Floor Myofascial Pain Might Influence Treatment Outcome of Interstitial Cystitis/Bladder Pain Syndrome: A Prospective Study.
    Yu WR; Chuang FC; Chang WC; Kuo HC
    Pain Physician; 2022 Nov; 25(8):E1315-E1322. PubMed ID: 36375205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.